DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Tolaney SM, Barry WT, Guo H. et al.
Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC).
J Clin Oncol 2017;
35 (no. 15_suppl): 511
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.